BioTech OPPORTUNITY ANALYSIS

GlucoPilot: A real-time, edge-computing AI layer that integrates with existing CGM data to provide sub-second insulin bolus recommendations, reducing manual intervention by 90%.

Validated on That's Missing platform | Status: Active Opportunity

Market Catalyst & News Trigger

"FDA announces accelerated pathway for closed-loop AI-driven insulin dosing systems in Type 1 Diabetes"

Source: TechCrunch | Published: 9/8/2026

The Workflow Friction

Type 1 diabetes patients suffer from 'decision fatigue' and hypoglycemic events; current manual dosing takes 15-20 minutes per day, leading to 12-15% HbA1c deviation and $4,500/year in emergency care costs.

Problem Summary

Real-world problem signal validation.

One-Shot MVP Builder Blueprint (48 Hours)

Core flow: CGM Data Ingestion -> Edge AI Inference (Bolus Calc) -> User Confirmation UI -> Dosage Log Dashboard. MVP includes a 'Shadow Mode' where AI suggests doses without executing, allowing user trust calibration over 30 days.

Recommended Developer Tech Stack

  • Flutter
  • Python (PyTorch)
  • TimescaleDB